Inactive Instrument

Other languages LogicBio Therapeutics, Inc.

Equities

LOGC

US54142F1021

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

CANbridge Pharmaceuticals Inc. Announces Update on Collaborations with the Umass Chan Medical School and with Logicbio Therapeutics	23-01-03
LogicBio Therapeutics, Inc. Announces Management Changes	22-11-16
AstraZeneca Unit Completes Acquisition of LogicBio Therapeutics	22-11-16
Alexion Pharmaceuticals, Inc. completed the acquisition of LogicBio Therapeutics, Inc. from a group of shareholders.	22-11-14
LogicBio Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
LogicBio Therapeutics, Inc. and CANbridge Care Pharma Hong Kong Limited Enter into the Amended and Restated Exclusive Research Collaboration, License and Option Agreement	22-10-07
Bolsa de Madrid: El mercado intenta una nueva partitura	22-10-04
Le marché essaie une nouvelle partition	22-10-04
EN DIRECT DES MARCHES : Saint-Gobain, Atos, M6, Kaufman, Aston Martin, Nestlé, Pfizer, Sika...	22-10-04
AstraZeneca Unit To Buy US Biotech LogicBio Therapeutics	22-10-03
Sector Update: Health Care Stocks Catching Up With Broader Market Gains	22-10-03
Sector Update: Health Care Stocks Mostly Higher in Afternoon Trading	22-10-03
AstraZeneca Unit to Acquire LogicBio Therapeutics; LogicBio Shares Soar	22-10-03
Sector Update: Health Care	22-10-03
Sector Update: Health Care Stocks Edge Higher Premarket Monday	22-10-03
Sector Update: Health Care	22-10-03
AstraZeneca pays 660% premium for gene therapy firm LogicBio	22-10-03
AstraZeneca Unit to Acquire LogicBio Therapeutics; LogicBio Shares Soar	22-10-03
LogicBio Therapeutics, Inc Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE	22-09-21
LogicBio Therapeutics, Inc. Announces Executive Changes	22-09-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages LogicBio Therapeutics, Inc.

Equities

LOGC

US54142F1021

Other languages

Filters